Sanofi SNY
NASDAQ SNY
$41.60 -0.36 (-0.86%)
At close: Oct 23, 2026 · 4:00 PM EDT

Sanofi (SNY) EBITDA Margin (2009 - 2026)

Updated

Sanofi (SNY) posted EBITDA Margin of 30.89% for the quarter ended Jun 30, 2026, up 1.84 percentage points from 29.05% a year earlier and up 7.42 percentage points from the prior quarter.

Analysis

Sanofi (SNY) EBITDA Margin (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Sanofi was 14.82%, down 14.16 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at 27.56%, up 1.17 percentage points from the prior year.

  • Annual EBITDA Margin shows a five-year change of -21.79 percentage points (years ended Dec 2020 to Dec 2025).
  • In prior years, Sanofi's EBITDA Margin was 26.38% in the year ended Dec 31, 2024 (-3.73 pp), 30.12% in the year ended Dec 31, 2023 (-5.13 pp), 35.24% in the year ended Dec 31, 2022 (+4.85 pp) and 30.39% in the year ended Dec 31, 2021 (-18.95 pp).
  • The figure for the quarter ended Jun 30, 2026 stands as the highest quarterly EBITDA Margin since the quarter ended Dec 31, 2024.
  • On a year-over-year basis, EBITDA Margin increased in four of the last seven quarters, with an average year-over-year change of -15.17 percentage points.
  • The strongest year-over-year quarter for EBITDA Margin in the past five years was the quarter ended Mar 31, 2025, with a gain of 9.11 percentage points; the weakest was the quarter ended Dec 31, 2024, with a drop of 116.54 percentage points.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 32.68%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 49.01%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 6.02%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 33.11%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 46.01%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -124.26%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 39.16%
10 Sanofi 50.74 Bn 17.26 Bn 10.79 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 15.09%
Mar 31, 2025 26.62%
Dec 31, 2024 32.93%
Mar 31, 2024 17.51%
Dec 31, 2023 16.52%
Mar 31, 2023 27.71%
Dec 31, 2022 53.05%
Mar 31, 2022 28.51%
Dec 31, 2021 29.45%
Mar 31, 2021 27.98%
Mar 31, 2020 26.89%
Mar 31, 2019 21.14%
Dec 31, 2018 11.20%
Dec 31, 2015 20.61%
Dec 31, 2014 34.47%
Dec 31, 2013 8.22%
Dec 31, 2012 19.94%
Dec 31, 2011 24.67%
Dec 31, 2010 17.93%
Dec 31, 2009 154.55%
API Access

Sanofi EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SNY&period=max&api_key=YOUR_API_KEY